260 related articles for article (PubMed ID: 19101354)
1. [Clinical and therapeutic aspects of agitation].
San L
Encephale; 2007 Jun; 33 Pt 3():S375-9. PubMed ID: 19101354
[No Abstract] [Full Text] [Related]
2. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia.
Wright P; Birkett M; David SR; Meehan K; Ferchland I; Alaka KJ; Saunders JC; Krueger J; Bradley P; San L; Bernardo M; Reinstein M; Breier A
Am J Psychiatry; 2001 Jul; 158(7):1149-51. PubMed ID: 11431240
[TBL] [Abstract][Full Text] [Related]
3. Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia.
Kinon BJ; Roychowdhury SM; Milton DR; Hill AL
J Clin Psychiatry; 2001; 62 Suppl 2():17-21. PubMed ID: 11232746
[TBL] [Abstract][Full Text] [Related]
4. Intramuscular olanzapine versus short-acting typical intramuscular antipsychotics: comparison of real-life effectiveness in the treatment of agitation.
Castle DJ; Udristoiu T; Kim CY; Sarosi A; Pidrman V; Omar AN; Rosales JI; Melamed Y; Isik T; Karagianis J; Treuer T
World J Biol Psychiatry; 2009; 10(1):43-53. PubMed ID: 19137460
[TBL] [Abstract][Full Text] [Related]
5. A naturalistic multicenter study of intramuscular olanzapine in the treatment of acutely agitated manic or schizophrenic patients.
San L; Arranz B; Querejeta I; Barrio S; De la Gándara J; Pérez V
Eur Psychiatry; 2006 Dec; 21(8):539-43. PubMed ID: 16697151
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of a rapid-acting intramuscular formulation of olanzapine for positive symptoms.
Jones B; Taylor CC; Meehan K
J Clin Psychiatry; 2001; 62 Suppl 2():22-4. PubMed ID: 11232747
[TBL] [Abstract][Full Text] [Related]
7. A post hoc analysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with schizophrenia.
Chengappa KN; Goldstein JM; Greenwood M; John V; Levine J
Clin Ther; 2003 Feb; 25(2):530-41. PubMed ID: 12749512
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, randomized comparison study of efficacy and safety of intramuscular olanzapine and intramuscular haloperidol in patients with schizophrenia and acute agitated behavior.
Chan HY; Ree SC; Su LW; Chen JJ; Chou SY; Chen CK; Chen YS
J Clin Psychopharmacol; 2014 Jun; 34(3):355-8. PubMed ID: 24743717
[TBL] [Abstract][Full Text] [Related]
9. Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation.
Villari V; Rocca P; Fonzo V; Montemagni C; Pandullo P; Bogetto F
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):405-13. PubMed ID: 17900775
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the use of the positive and negative syndrome scale-excited component as a criterion for administration of p.r.n. medication.
Chaichan W
J Psychiatr Pract; 2008 Mar; 14(2):105-13. PubMed ID: 18360196
[TBL] [Abstract][Full Text] [Related]
11. Treatment of agitation in the acute psychiatric setting. An observational study of the effectiveness of intramuscular psychotropic medication.
Bauer JØ; Stenborg D; Lodahl T; Mønsted MM
Nord J Psychiatry; 2016 Nov; 70(8):599-605. PubMed ID: 27284637
[TBL] [Abstract][Full Text] [Related]
12. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.
Krakowski MI; Czobor P; Citrome L; Bark N; Cooper TB
Arch Gen Psychiatry; 2006 Jun; 63(6):622-9. PubMed ID: 16754835
[TBL] [Abstract][Full Text] [Related]
13. A post hoc analysis of transitioning to oral treatment with olanzapine or haloperidol after 24-hour intramuscular treatment in acutely agitated adult patients with schizophrenia.
Battaglia J; Houston JP; Ahl J; Meyers AL; Kaiser CJ
Clin Ther; 2005 Oct; 27(10):1612-8. PubMed ID: 16330297
[TBL] [Abstract][Full Text] [Related]
14. Effect of aripiprazole lauroxil on agitation and hostility in patients with schizophrenia.
Citrome L; Du Y; Risinger R; Stankovic S; Claxton A; Zummo J; Bose A; Silverman BL; Ehrich EW
Int Clin Psychopharmacol; 2016 Mar; 31(2):69-75. PubMed ID: 26517202
[TBL] [Abstract][Full Text] [Related]
15. Intramuscular aripiprazole in the control of agitation.
Currier GW; Citrome LL; Zimbroff DL; Oren D; Manos G; McQuade R; Pikalov AA; Crandall DT
J Psychiatr Pract; 2007 May; 13(3):159-69. PubMed ID: 17522559
[TBL] [Abstract][Full Text] [Related]
16. The role of typical and atypical antipsychotic medications in the management of agitation and aggression.
Buckley PF
J Clin Psychiatry; 1999; 60 Suppl 10():52-60. PubMed ID: 10340688
[TBL] [Abstract][Full Text] [Related]
17. Are high initial doses of olanzapine required to reduce agitation associated with schizophrenia?
Townsend MH; Baier MB
J Clin Psychopharmacol; 2004 Feb; 24(1):95-7. PubMed ID: 14709956
[No Abstract] [Full Text] [Related]
18. Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis.
Gobbi G; Gaudreau PO; Leblanc N
J Clin Psychopharmacol; 2006 Oct; 26(5):467-73. PubMed ID: 16974186
[TBL] [Abstract][Full Text] [Related]
19. Chronic restlessness with antipsychotics.
Bratti IM; Kane JM; Marder SR
Am J Psychiatry; 2007 Nov; 164(11):1648-54. PubMed ID: 17974927
[No Abstract] [Full Text] [Related]
20. Atypical antipsychotic medications in the psychiatric emergency service.
Currier GW
J Clin Psychiatry; 2000; 61 Suppl 14():21-6. PubMed ID: 11154013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
